OverviewSuggest Edit
Organigram is a producer of medical cannabis and cannabis-derived products. The company offers indoor-grown cannabis for patients and adult recreational consumers. Its portfolio of legal adult use recreational cannabis brands includes Edison Cannabis, ANKR Organics, and Trailblazer.
| Type | Public | |
| Founded | 2013 | |
| HQ | Moncton, CA | Map |
| Website | organigram.ca |
Recent NewsAll News
- CEO’s of OrganiGram, Icanic Brands, Red Light Holland, and Sundial Growers, Driving New Growth Opportunities in Cannabis and Psychedelics
- OrganiGram stock drops after cannabis company reports wider loss, revenue miss
- Cannabis company Organigram posts wider-than-expected loss as revenue falls short in Q4
- Canadian cannabis company OrganiGram loss widens in latest quarter as revenue falls short of estimates
Key People/Management at Organigram
Gregory Engel
Chief Executive Officer, Director
Amy Schwalm
Vice President, Investor Relations
Paolo de Luca
Chief Strategy Officer
Tim Emberg
Senior Vice President, Sales and Commercial Operations
Helen Martin
Senior Vice President, Strategic and Legal Affairs
Derrick West
Chief Financial Officer
Organigram Office Locations
Organigram has offices in Moncton and Toronto
Moncton, CA (HQ)
35 English Dr
Toronto, CA
Bay Adelaide Centre, 333 Bay St #1250
Organigram Financials and Metrics
Organigram Revenue
Organigram's revenue was reported to be C$80.41 m in FY, 2019 which is a 547% increase from the previous period.
| CAD | |
|---|---|
Revenue (Q1, 2020) | 25.2m |
Gross profit (Q1, 2020) | 11.2m |
Gross profit margin (Q1, 2020), % | 44.5% |
Net income (Q1, 2020) | (863.0k) |
EBIT (Q1, 2020) | 154.0k |
Market capitalization (25-Feb-2021) | 891.5m |
Closing stock price (25-Feb-2021) | 3.8 |
Cash (30-Nov-2019) | 34.0m |
EV | 942.0m |
Organigram's current market capitalization is C$891.5 m.
Annual
Quarterly
| CAD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.2m | (581.2k) | 1.9m | 2.7m | 3.7m | 3.7m | 12.4m | 26.9m | 24.8m | 25.2m |
Cost of goods sold | 1.5m | 3.4m | 2.7m | 1.1m | 1.4m | 1.3m | 2.9m | 19.0m | 24.9m | 14.0m |
Gross profit | 762.9k | (4.0m) | (757.4k) | 1.6m | 2.3m | 2.4m | 9.5m | 8.0m | (179.0k) | 11.2m |
Gross profit Margin, % | 34% | 684% | (40%) | 60% | 63% | 65% | 77% | 30% | (1%) | 45% |
Annual
Quarterly
| CAD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 7.6m | 1.3m | 2.7m | 7.6m | 53.7m | 31.6m | 30.2m | 12.5m | 47.2m | 34.0m |
Accounts Receivable | 514.0k | 1.1m | 541.6k | 514.0k | 995.0k | 795.0k | 11.2m | 21.7m | 14.6m | 13.5m |
Prepaid Expenses | 1.8m | 473.6k | 847.3k | 1.8m | 1.7m | 1.3m | 1.0m | 1.4m | 11.9m | 11.6m |
Inventories | 4.2m | 2.7m | 2.0m | 4.2m | 8.7m | 17.6m | 91.4m | 95.1m | 94.2m | 101.9m |
Annual
Quarterly
| CAD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (1.4m) | (6.5m) | (8.9m) | (1.4m) | (324.1k) | 2.5m | 29.5m | 23.1m | 13.0m | (863.0k) |
Depreciation and Amortization | 480.1k | 665.8k | 1.0m | 480.1k | 1.1m | 2.0m | 1.7m | 3.5m | 5.7m | 3.4m |
Inventories | (1.6m) | 1.3m | 1.9m | (1.6m) | (6.1m) | (14.9m) | (46.5m) | (50.2m) | (49.2m) | (8.8m) |
Accounts Payable | 513.5k | 2.7m | 1.5m | 513.5k | 5.5m | 2.4m | (2.9m) | (5.2m) | 3.2m | (10.9m) |
| CAD | Q1, 2017 |
|---|---|
Financial Leverage | 1.1 x |
Organigram Operating Metrics
Organigram's Patients was reported to be 18.1 k in Q1, 2020.
| Q1, 2017 | Q2, 2017 | Q3, 2017 | Q4, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q4, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q4, 2019 | Q1, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brands | 5 | 5 | 5 | 4 | 4 | 3 | |||||||
Cannabis Harvested, kilograms | 8.32 k | 6.05 k | 7.43 k | 12.76 k | |||||||||
Cannabis Sold, kilogram and kilogram equivalents | 4.99 k | 4.62 k | 2.90 k | 5.50 k | |||||||||
Patients | 4 k | 4.04 k | 5.51 k | 7.40 k | 10.73 k | 12.96 k | 15.32 k | 15.73 k | 13.51 k | 14.88 k | 17 k | 17.20 k | 18.13 k |
Organigram Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Organigram Inc. |
Organigram Cybersecurity Score
Organigram Online and Social Media Presence
20k Twitter followers
Organigram has 20k Twitter Followers. The number of followers has increased 4.1% month over month and increased 4% quarter over quarter
Organigram's Trends
Twitter Engagement Stats for @discoverOGI
1.2k
Tweets
298
Following
20k
Followers
3
Tweets last 30 days
3
Avg. likes per Tweet
100%
Tweets with engagement
Organigram News and Updates
February 09, 2021
CEO’s of OrganiGram, Icanic Brands, Red Light Holland, and Sundial Growers, Driving New Growth Opportunities in Cannabis and Psychedelics
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Red Light Holland (OTC: TRUFF) (CSE…
January 12, 2021
OrganiGram stock drops after cannabis company reports wider loss, revenue miss
The U.S.-listed shares of OrganiGram Holdings Inc. dropped 2.3% in premarket trading, as the Canada-based cannabis company reported a much wider fiscal first-quarter net loss and net revenue that fell more than forecast, while adult-use recreational cannabis revenue jumped. The net loss for the qua…
July 21, 2020
Cannabis company Organigram posts wider-than-expected loss as revenue falls short in Q4
Canadian cannabis company Organigram Inc. said Tuesday it had a net loss of C$89.9 million ($66.6 million), or 51 cents a share, in its fiscal third quarter to May 31, wider than the net loss of C$10.2 million, or 7 cents a share, posted in the year-earlier period. Revenue net of excise taxes fell …
April 14, 2020
Canadian cannabis company OrganiGram loss widens in latest quarter as revenue falls short of estimates
Canadian cannabis company OrganiGram Holdings Inc. said Tuesday it had a net loss of C$6.8 million ($4.9 million), or 41 cents a share, in its fiscal second quarter to Feb. 29, wider than the loss of C$6.4 million, or 49 cents a share, posted in the year-earlier period. Revenue fell to C$23.2 milli…
March 04, 2020
OrganiGram CFO De Luca to be chief strategy officer, board member West to be CFO
OrganiGram Holdings Inc. said Wednesday it named current Chief Financial Officer Paolo De Luca as its chief strategy officer, while current board member Derrick West will join the company as CFO, effective immediately. De Luca has been CFO since December 2017. West was most recently a member of th…
November 25, 2019
Organigram posts wider-than-expected loss, weaker revenue than expected for Q4
Canadian cannabis company Organigram Holdings Inc. said Monday it had a net loss of C$22.5 million ($16.9 million), or 14 cents a share, in its fiscal fourth quarter to Aug. 31, after a profit of C$18.2 million, or 12 cents a share, in the year-earlier period. Revenue net of excise taxes came to C$…
Organigram Frequently Asked Questions
When was Organigram founded?
Organigram was founded in 2013.
Who are Organigram key executives?
Organigram's key executives are Gregory Engel, Amy Schwalm and Paolo de Luca.
How many employees does Organigram have?
Organigram has 770 employees.
What is Organigram revenue?
Latest Organigram annual revenue is C$80.4 m.
What is Organigram revenue per employee?
Latest Organigram revenue per employee is C$104.4 k.
Who are Organigram competitors?
Competitors of Organigram include DionyMed Holdings, Aphria and Auxly.
Where is Organigram headquarters?
Organigram headquarters is located at 35 English Dr, Moncton.
Where are Organigram offices?
Organigram has offices in Moncton and Toronto.
How many offices does Organigram have?
Organigram has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies